ADVERTISEMENT
India’s Covid Vaccine TRIPs Somewhere Between Doha And Riyadh
The pandemic has highlighted the challenges that the global patent system poses to public health, writes Murali Neelakantan.
02 Dec 2020, 07:44 PM IST ![NDTV Profit](/icons/feather-without-circle.svg)
![NDTV Profit](/icons/timer.svg)
![A seasonal influenza vaccine is administered with a syringe, on Nov. 24, 2020. (Photographer: Alex Kraus/Bloomberg)](https://media.assettype.com/bloombergquint%2F2020-12%2F39ad5ef9-3826-417c-9b48-0e7f51a23e2d%2F366249961.jpg?rect=0%2C417%2C4000%2C2250&auto=format%2Ccompress&w=200)
A seasonal influenza vaccine is administered with a syringe, on Nov. 24, 2020. (Photographer: Alex Kraus/Bloomberg)
The pandemic has once again highlighted the conflict between intellectual property rights and public health with scientists, health activists and lawyers calling for an “Open Covid Pledge” so that (i) patents and other IPR barriers to the widespread manufacture and distribution of the vaccines are suspended and (ii) all knowhow and trade secrets are shared. Most of us naively believed that this conflict was settled in the Doha Declar...
![](/images/white_gradient.png)
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
Access to
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Members-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Members-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
ADVERTISEMENT